Home Blood Pressure Monitoring, Treatment Adherence and Hypertension Control

  • Alejandro de la SierraEmail author
  • Anastasia Mihailidou
  • Ji-Guang Wang
  • Daichi Shimbo
  • Richard J. McManus
Part of the Updates in Hypertension and Cardiovascular Protection book series (UHCP)


Home blood pressure monitoring (HBPM) is superior to clinic BP in predicting cardiovascular events in hypertension and helps diagnostic and therapeutic decisions by identifying different hypertension phenotypes, such as white-coat and masked hypertension. In addition to these main advantages of HBPM, several studies have evaluated its impact on long-term management, especially on medication adherence and on BP reduction and control.

In randomized studies versus usual care (decisions based on office BP readings), HBPM has been associated with significant modest improvements in medication adherence, an effect that is usually more evident when HBPM has been a part of other interventions, such as lifestyle counselling and/or adherence reminders. Concerning the effect on BP, again the results of clinical trials and meta-analyses have shown a significant effect on BP reduction when HBPM is added to management. Mean effect on systolic BP at 12 months has been quantified in approximately 3 mmHg, although again positive studies usually combine other interventions, while the isolated use of HBPM has a considerably smaller effect. Intervention studies have also examined the effect of self-management (modifications of antihypertensive treatment by the patient according to a protocol based on HBP measures) and telemonitoring (tele-transmission of data to the physician or to the pharmacist and treatment modifications by health care providers). Results indicate that self-management combined with HBPM has an important impact in reducing BP, provided there is specific training and with the proviso that not all patients will be suitable. Studies with telemonitoring are more controversial. Under strict experimental conditions, it does not seem to improve the effect of HBPM alone. However, even though the marginal benefits of telemonitoring on daily practice compared to manual methods are difficult to measure, they may bring significant improvements, easing integration of self-monitored blood pressure into clinical records. Therefore, it presents an opportunity for an improvement in long-term BP management.


Home blood pressure monitoring Hypertension Antihypertensive treatment Treatment adherence Hypertension control 


  1. 1.
    Whelton PK, Carey RM, Aronow WS, Casey DE Jr, Collins KJ, Dennison Himmelfarb C, et al. 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA guideline for the prevention, detection, evaluation, and management of high blood pressure in adults: executive summary: a report of the American College of Cardiology/American Heart Association task force on clinical practice guidelines. Hypertension. 2018;71(6):1269–324.CrossRefGoogle Scholar
  2. 2.
    Williams B, Mancia G, Spiering W, Agabiti Rosei E, Azizi M, Burnier M, et al. 2018 ESC/ESH guidelines for the management of arterial hypertension: the task force for the management of arterial hypertension of the European Society of Cardiology and the European Society of Hypertension: the task force for the management of arterial hypertension of the European Society of Cardiology and the European Society of Hypertension. J Hypertens. 2018;36(10):1953–2041.CrossRefGoogle Scholar
  3. 3.
    Vrijens B, Antoniou S, Burnier M, de la Sierra A, Volpe M. Current situation of medication adherence in hypertension. Front Pharmacol. 2017;8:100.CrossRefGoogle Scholar
  4. 4.
    Jung O, Gechter JL, Wunder C, Paulke A, Bartel C, Geiger H, et al. Resistant hypertension? Assessment of adherence by toxicological urine analysis. J Hypertens. 2013;31(4):766–74.CrossRefGoogle Scholar
  5. 5.
    Corrao G, Parodi A, Nicotra F, Zambon A, Merlino L, Cesana G, et al. Better compliance to antihypertensive medications reduces cardiovascular risk. J Hypertens. 2011;29(3):610–8.CrossRefGoogle Scholar
  6. 6.
    Ogedegbe G, Schoenthaler A. A systematic review of the effects of home blood pressure monitoring on medication adherence. J Clin Hypertens (Greenwich). 2006;8(3):174–80.CrossRefGoogle Scholar
  7. 7.
    Vrijens B, Goetghebeur E. Comparing compliance patterns between randomized treatments. Control Clin Trials. 1997;18(3):187–203.CrossRefGoogle Scholar
  8. 8.
    Bailey B, Carney SL, Gillies AA, Smith AJ. Antihypertensive drug treatment: a comparison of usual care with self blood pressure measurement. J Hum Hypertens. 1999;13(2):147–50.CrossRefGoogle Scholar
  9. 9.
    Fletcher BR, Hartmann-Boyce J, Hinton L, McManus RJ. The effect of self-monitoring of blood pressure on medication adherence and lifestyle factors: a systematic review and meta-analysis. Am J Hypertens. 2015;28(10):1209–21.CrossRefGoogle Scholar
  10. 10.
    Margolis KL, Asche SE, Dehmer SP, Bergdall AR, Green BB, Sperl-Hillen JM, et al. Long-term outcomes of the effects home blood pressure telemonitoring and pharmacist management on blood pressure among adults with uncontrolled hypertension. Follow-up of a cluster randomized clinical trial. JAMA Netw Open. 2018;1(5):e181617.CrossRefGoogle Scholar
  11. 11.
    Cappuccio FP, Kerry SM, Forbes L, Donald A. Blood pressure control by home monitoring: meta-analysis of randomised trials. BMJ. 2004;329(7458):145.CrossRefGoogle Scholar
  12. 12.
    Agarwal R, Bills JE, Hecht TJ, Light RP. Role of home blood pressure monitoring in overcoming therapeutic inertia and improving hypertension control: a systematic review and meta-analysis. Hypertension. 2011;57(1):29–38.CrossRefGoogle Scholar
  13. 13.
    Uhlig K, Patel K, Ip S, Kitsios GD, Balk EM. Self-measured blood pressure monitoring in the management of hypertension: a systematic review and meta-analysis. Ann Intern Med. 2013;159(3):185–94.CrossRefGoogle Scholar
  14. 14.
    Tucker KL, Sheppard JP, Stevens R, Bosworth HB, Bove A, Bray EP, et al. Self-monitoring of blood pressure in hypertension: a systematic review and individual patient data meta-analysis. PLoS Med. 2017;14(9):e1002389.CrossRefGoogle Scholar
  15. 15.
    McManus RJ, Mant J, Bray EP, Holder R, Jones MI, Greenfield S, et al. Telemonitoring and self-management in the control of hypertension (TASMINH2): a randomised controlled trial. Lancet. 2010;376(9736):163–72.CrossRefGoogle Scholar
  16. 16.
    McManus RJ, Mant J, Haque MS, Bray EP, Bryan S, Greenfield SM, et al. Effect of self-monitoring and medication self-titration on systolic blood pressure in hypertensive patients at high risk of cardiovascular disease: the TASMIN-SR randomized clinical trial. JAMA. 2014;312(8):799–808.CrossRefGoogle Scholar
  17. 17.
    Margolis KL, Asche SE, Bergdall AR, Dehmer SP, Groen SE, Kadrmas HM, et al. Effect of home blood pressure telemonitoring and pharmacist management on blood pressure control: a cluster randomized clinical trial. JAMA. 2013;310(1):46–56.CrossRefGoogle Scholar
  18. 18.
    Omboni S, Gazzola T, Carabelli G, Parati G. Clinical usefulness and cost effectiveness of home blood pressure telemonitoring: meta-analysis of randomized controlled studies. J Hypertens. 2013;31(3):455–67.CrossRefGoogle Scholar
  19. 19.
    Duan Y, Xie Z, Dong F, Wu Z, Lin Z, Sun N, et al. Effectiveness of home blood pressure telemonitoring: a systematic review and meta-analysis of randomised controlled studies. J Hum Hypertens. 2017;31(7):427–37.CrossRefGoogle Scholar
  20. 20.
    McManus RJ, Mant J, Franssen M, Nickless A, Schwartz C, Hodgkinson J, et al. Efficacy of self-monitored blood pressure, with or without telemonitoring, for titration of antihypertensive medication (TASMINH4): an unmasked randomised controlled trial. Lancet. 2018;391(10124):949–59.CrossRefGoogle Scholar

Copyright information

© The Editor(s) (if applicable) and The Author(s), under exclusive license to Springer Nature Switzerland AG, part of Springer Nature 2020

Authors and Affiliations

  • Alejandro de la Sierra
    • 1
    Email author
  • Anastasia Mihailidou
    • 2
    • 3
  • Ji-Guang Wang
    • 4
  • Daichi Shimbo
    • 5
  • Richard J. McManus
    • 6
  1. 1.Department of Internal MedicineHospital Mutua Terrassa, University of BarcelonaBarcelonaSpain
  2. 2.Cardiovascular & Hormonal Research Laboratory, Department of Cardiology and Kolling InstituteRoyal North Shore HospitalSydneyAustralia
  3. 3.Macquarie UniversitySydneyAustralia
  4. 4.The Shanghai Institute of HypertensionRuijin Hospital, Shanghai Jiaotong University School of MedicineShanghaiChina
  5. 5.Department of MedicineColumbia University Medical CenterNew YorkUSA
  6. 6.Nuffield Department of Primary Care Health SciencesUniversity of Oxford, Radcliffe Observatory QuarterOxfordUK

Personalised recommendations